Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
focused on polymeric functional and particulate materials. The candidate will play a key role in translating lab-scale innovations into demonstrator and pilot-scale processes, and will contribute to reactor
-
the clinic and in silico. We focus on neurodegenerative processes and are especially interested in Alzheimer's and Parkinson's disease and their contributing factors. The LCSB recruits talented scientists from
-
the clinic and in silico. We focus on neurodegenerative processes and are especially interested in Alzheimer's and Parkinson's disease and their contributing factors. The LCSB recruits talented scientists from
-
BioEngineering Experience with fluidics devices, 3D printed devices, 3D cell culture models and bioinformatics/computational biology (e.g., R, Python) is an asset Team player Proficient knowledge in English is
-
the clinic and in silico. We focus on neurodegenerative processes and are especially interested in Alzheimer's and Parkinson's disease and their contributing factors. The LCSB recruits talented scientists from
-
. This post doc offer (12 months) is part of the European project IHI Accelerate.EU aiming at developing 211At-based radiotheranostic pairs to treat cancers (https://ihi-accelerate.eu/). Astatine-211 is an
-
the clinic and in silico. We focus on neurodegenerative processes and are especially interested in Alzheimer's and Parkinson's disease and their contributing factors. The LCSB recruits talented scientists from
-
of programming, learning theory, parallel algorithms or quantum computing Research publications in theoretical computer science conferences and journals Experience in teaching Computer Science topics
-
the Bioinformatics Core Facility and Head of the ELIXIR-Luxembourg Node. Early application is highly encouraged, as the applications will be processed upon reception. To ensure full consideration, candidates should
-
protein expression and purification, capable of producing thousands of proteins in parallel within weeks . 2) Eukaryotic expression systems facility for production of challenging protein targets. 3) A fully